Meredith Promotes Controversial Stem Cell Therapy to Staffers

Des Moines Register: Meredith former CEO Steve Lacy said he underwent a Regenexx procedure after his company began covering stem cell treatments. Lacy had been facing knee surgery. Meredith has spent about $400,000 in four years on 85 employees who have had Regenexx treatments.